- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (113)
- Timeline of Article Publication (20)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5183)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2023 (publication date) through Feb 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi YJ, Dong GJ, Guo M. Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus. World J Diabetes 2023; 14(6): 724-740 [PMID: 37383601 DOI: 10.4239/wjd.v14.i6.724] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i6/724.htm |
| Number | Citing Articles |
| 1 |
Tian-Yu Wang, Qiang Yang, Xin-Yi Cheng, Jun-Can Ding, Peng-Fei Hu. Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction. Heart Failure Reviews 2024; 30(1): 17 doi: 10.1007/s10741-024-10438-2
|
| 2 |
Qiuxuan Li, Ur Rehman Muhib, Xiaoteng Ma, Zaiqiang Liu, Fei Gao, Zhijian Wang. Potential Mechanisms of Epicardial Adipose Tissue Influencing Heart Failure with Preserved Ejection Fraction. Reviews in Cardiovascular Medicine 2024; 25(9) doi: 10.31083/j.rcm2509311
|
| 3 |
Yuanwei Xu, Jiajun Guo, Yangjie Li, Shiqian Wang, Ke Wan, Weihao Li, Jie Wang, Ziqian Xu, Wei Cheng, Jiayu Sun, Qing Zhang, Yuchi Han, Yucheng Chen. Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathy. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02517-3
|
| 4 |
Ruijue Huang, Wenjia Li, Zhen Xie, Kaimin Zhuo, Jing Zhu. Epicardial Adipose Tissue and Major Adverse Cardiovascular Events in Myocardial Infarction Patients with and without Diabetes. Academic Radiology 2024; 31(9): 3546 doi: 10.1016/j.acra.2024.04.001
|
| 5 |
Martina Vincenzi, Canan G. Nebigil. Uncovering the Role of Prokineticin Pathway on Epicardial Adipose Tissue (EAT) Development and EAT-Associated Cardiomyopathy. Trends in Cardiovascular Medicine 2025; doi: 10.1016/j.tcm.2025.02.006
|
| 6 |
Julita Tokarek, Emilian Budny, Maciej Saar, Kamila Stańczak, Ewa Wojtanowska, Ewelina Młynarska, Jacek Rysz, Beata Franczyk. Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes. Biomedicines 2023; 11(10): 2611 doi: 10.3390/biomedicines11102611
|
| 7 |
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, A. N. Ryabikov. Extended-release metformin in patients with prediabetes, chronic heart failure and abdominal obesity in light of the effect on fat depot compartments and glucose metabolism parameters. Diabetes mellitus 2024; 27(4): 357 doi: 10.14341/DM13189
|
| 8 |
O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, A. N. Ryabikov, E. V. Kashtanova. Long-term effects of metformin on fat depots and insulin-glucose parameters in patients with prediabetes and chronic heart failure. Meditsinskiy sovet = Medical Council 2024; (16): 274 doi: 10.21518/ms2024-347
|